About Andrew

Andrew Limbek is a Director in the Firm’s Financial Accounting and Advisory (FAAS) services practice. Mr. Limbek has more than 13 years of experience in financial reporting and analysis, public company compliance, technical accounting, process improvement, financial modeling and due diligence.

Mr. Limbek’s technical expertise includes US GAAP, internal controls (SOX) and SEC reporting (10-K, S-8, S-1, DEF 14A). Mr. Limbek has provided services to both private and public companies with a particular focus on the clinical laboratories, life sciences, and professional services industries. Mr. Limbek’s advisory and private experience, coupled with his collaborative approach with clients, allow him to build tailor-made solutions that fit the need of the company and respond to the expectation of its auditors, board of directors and shareholders.

Prior to joining Marcum, Mr. Limbek served as the principal financial officer at Psychemedics Corporation (NASDAQ: PMD). At PMD, Mr. Limbek was responsible to the board of directors for all accounting and financial matters. Mr. Limbek oversaw key components of the finance function such as financial planning, accounting, tax compliance, and financial reporting, to name a few.

Mr. Limbek earned a Bachelor of Science in Business Administration with a concentration in Accounting from the University of New Hampshire and he is a Certified Public Accountant licensed by the Commonwealth of Massachusetts.

Professional & Civic Affiliations

  • American Institute of Certified Public Accountants (AICPA)
Practice Focus

Technical Accounting
Financial Reporting
SEC Compliance
Corporate Finance
Budgeting and Forecasting
Cash Flow Analysis
Internal Audit & Sarbanes-Oxley Compliance
System Implementations

Industry Focus

Public & Private Companies
SEC
Professional Services
Life Sciences & Biotech
Clinical Laboratories

Education

Bachelor of Science, Accounting
University of New Hampshire